DIAGNOSIS AND TREATMENT HISTORY BEFORE PSORIASIS DIAGNOSIS AMONG PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS

被引：0
|
作者：
Feldman, S. R. [1 ]
Zhao, Y. [2 ]
Hur, P. [2 ]
Liu, J. S. [3 ]
Herrera, V [2 ]
机构：
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Harvard Univ, Cambridge, MA 02138 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS4
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [31] Patterns for phototherapy use in treatment of moderate-to-severe psoriasis
    Kulkarni, AS
    Horn, E
    Balkrishnan, R
    Feldman, SR
    VALUE IN HEALTH, 2006, 9 (03) : A170 - A170
  • [32] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [33] Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis
    Zhou, Yi
    Ding, Yantao
    Cui, Mengxing
    Zhang, Yuanjing
    Wang, Mengwei
    Zhou, Feiran
    Su, Yi
    Liang, Bo
    Zhou, Fusheng
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [34] Improvement in the psoriasis symptom inventory in moderate-to-severe psoriasis patients on etanercept or adalimumab
    Patel, Mira
    Martin, Mona
    Ortmeier, Brian
    Kricorian, Greg
    Wade, Sally
    Stolshek, Bradley
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB163 - AB163
  • [35] Nail psoriasis as a predictor of skin response to ixekizumab in patients with moderate-to-severe psoriasis
    Rich, P.
    Goldblum, O.
    Amato, D.
    Disch, D.
    Muram, D.
    Merola, J. F.
    Elewski, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S67 - S67
  • [36] Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
    Verbenko, Dmitry A.
    Karamova, Arfenya E.
    Artamonova, Olga G.
    Deryabin, Dmitry G.
    Rakitko, Alexander
    Chernitsov, Alexandr
    Krasnenko, Anna
    Elmuratov, Artem
    Solomka, Victoria S.
    Kubanov, Alexey A.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (01): : 1 - 12
  • [37] LONG-TERM TREATMENT PATTERNS AMONG PATIENTS WHO DEVELOPED MODERATE-TO-SEVERE PSORIASIS
    Feldman, S. R.
    Zhao, Y.
    Hur, P.
    Liu, J. S.
    Herrera, V
    VALUE IN HEALTH, 2017, 20 (05) : A162 - A162
  • [38] PATIENTS' PERSPECTIVES ON THE IMPACT OF MODERATE-TO-SEVERE GENITAL PSORIASIS
    Cather, J. C.
    Bleakman, Potts A. P.
    Naegeli, A.
    Poon, J. L.
    Wallace, A.
    Hollister, K.
    Fretzin, S.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S65 - S66
  • [39] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [40] Glomerular filtration rate in patients with moderate-to-severe psoriasis
    Gisondi, P.
    Pezzolo, E.
    Girolomoni, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (06) : E244 - E246
12345